申请人:Campbell David A.
公开号:US20100120716A1
公开(公告)日:2010-05-13
Macrocyclic inhibitors of Hepatitis C protease are provided, the inhibitors including a boronic acid or ester group, a macrocyclic ring of about 13 to 25 atoms including at least two amide linkages, a proline-analogous group, and a connecting segment joining moieties on either side of the proline-analogous group. Methods of making the HCV protease-inhibitory compounds, methods of using the compounds, formulations of the compounds, and pharmaceutical combinations including the compounds, are provided.
本发明提供了肝炎C病毒蛋白酶的大环抑制剂,其中包括硼酸或酯基,大约13到25个原子的大环,包括至少两个酰胺键,脯氨酸类似物基团和连接段,连接在脯氨酸类似物基团两侧的基团。本发明还提供了制备HCV蛋白酶抑制剂化合物的方法,使用该化合物的方法,该化合物的配方以及包括该化合物的药物组合物。